News from the healthcare data industry
October 06, 2022 10:30 AM Eastern Daylight Time CHICAGO–(BUSINESS WIRE)–Tempus, a leader in artificial intelligence and precision medicine, today announced a new collaboration to develop a companion diagnostic (CDx) test...
Conduct disease-specific and disease-agnostic analyses Our disease-agnostic datasets combine 20 disease-specific data models with a lighter-weight data model for all other histologies to enable robust pan-tumor analyses. Patient data across...
The first Fully Digital, Clinical Trial Solution for Oncology, Hematology & Urology CAMBRIDGE, Mass., Sept. 29, 2022 /PRNewswire/ — ConcertAI, LLC (ConcertAI) announced the launch of its new Digital Trial Software-as-a-Service solution. Powered...
Collaboration Utilizes RWD-enabled Capabilities Across Hospitals and Research Organizations to Transform the Elimination of Disparities NEW ORLEANS and CAMBRIDGE, Mass., Sept. 27, 2022 /PRNewswire/ — The National Cancer Institute Community Oncology Research Program (NCI...
Partnership broadens precision medicine access at the point of care with seamless ordering and receipt of Caris molecular profiling results directly in patient records via the OncoEMR® platform IRVING, Texas, Sept....
By Patricia Allen Lausanne-headquartered Hedera Dx is pioneering the adoption of liquid biopsy in cancer treatments. The biotech startup has just raised €14 million to push forward its mission of bringing better...
September 21, 2022 07:00 AM Eastern Daylight Time CAMBRIDGE, Mass. & SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Foundation Medicine, Inc., a pioneer in molecular profiling for cancer, and Day One Biopharmaceuticals (Nasdaq: DAWN), a...
For a long time, doctors’ offices, large or small, operated under a seeming contradiction; even as modern medicine pushed the frontiers of innovation, providing new treatments and sometimes cures for...
SAN FRANCISCO and NEW YORK, Sept. 15, 2022 (GLOBE NEWSWIRE) — Syapse®, a leading real-world evidence company dedicated to extinguishing the fear and burden of serious diseases by advancing real-world care,...
September 12, 2022 06:30 AM Eastern Daylight Time CAMBRIDGE, Mass.–(BUSINESS WIRE)–Today Foundation Medicine, Inc., a pioneer in molecular profiling for cancer, and Relay Therapeutics (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the...